Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | ALNY | AMGN | GILD | CELG | BIIB |
Company | Alnylam Pharmaceuticals | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Biogen Inc |
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
Open | 144.08 | 265.72 | 65.50 | 108.01 | 201.22 |
High | 146.07 | 271.68 | 66.35 | 108.59 | 210.83 |
Low | 143.00 | 265.72 | 64.63 | 107.27 | 199.10 |
Last | 143.31 | 269.98 | 65.42 | 108.24 | 208.90 |
Change | -0.40 | +0.60 | +0.15 | +0.11 | +6.44 |
% Change | -0.28% | +0.22% | +0.23% | +0.10% | +3.18% |
Volume | 479,100 | 2,436,900 | 12,382,400 | 191,230,496 | 1,894,000 |
20-Day Average Volume | 491,800 | 2,156,940 | 7,062,390 | 16,188,930 | 1,280,100 |
Previous Close | 143.71 | 269.38 | 65.27 | 108.13 | 202.46 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | Yes | Yes | Yes | No | Yes |
Technicals | |||||
20-Day Moving Average | 148.86 | 269.99 | 68.29 | 108.17 | 201.13 |
20-Day Raw Stochastic | 7.69% | 40.03% | 9.20% | 63.25% | 74.13% |
20-Day Relative Strength | 37.65% | 45.47% | 29.21% | 64.69% | 49.77% |
Weighted Alpha | -30.42 | +9.45 | -23.49 | +46.30 | -31.63 |
Today's Opinion | 100% Sell | 72% Sell | 100% Sell | 100% Buy | 88% Sell |
Previous Opinion | 100% Sell | 72% Sell | 100% Sell | 100% Buy | 88% Sell |
Last Month's Opinion | 88% Sell | 40% Buy | 88% Sell | 100% Buy | 100% Sell |
Performance | |||||
5-Days | |||||
%Chg | -0.76% since 04/19/24 | +0.39% since 04/19/24 | -2.01% since 04/19/24 | -1.97% since 11/13/19 | +7.47% since 04/19/24 |
Low | 141.98 on 04/25/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 107.27 on 11/20/19 | 192.75 on 04/23/24 |
High | 150.27 on 04/23/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 110.53 on 11/14/19 | 210.83 on 04/26/24 |
1-Month | |||||
%Chg | -5.70% since 03/26/24 | -4.18% since 03/26/24 | -9.65% since 03/26/24 | +5.14% since 10/18/19 | -1.47% since 03/26/24 |
Low | 141.98 on 04/25/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 102.40 on 10/21/19 | 189.44 on 04/19/24 |
High | 159.34 on 04/09/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 110.70 on 11/13/19 | 217.57 on 03/28/24 |
3-Month | |||||
%Chg | -20.21% since 01/26/24 | -13.40% since 01/26/24 | -17.73% since 01/26/24 | +13.63% since 08/20/19 | -14.67% since 01/26/24 |
Low | 141.98 on 04/25/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 93.41 on 08/23/19 | 189.44 on 04/19/24 |
High | 181.66 on 01/30/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 110.70 on 11/13/19 | 251.99 on 01/31/24 |
6-Month | |||||
%Chg | -7.93% since 10/26/23 | +0.10% since 10/26/23 | -16.66% since 10/26/23 | +14.14% since 05/20/19 | -13.35% since 10/26/23 |
Low | 141.98 on 04/25/24 | 249.70 on 10/31/23 | 64.63 on 04/26/24 | 89.08 on 07/23/19 | 189.44 on 04/19/24 |
High | 199.38 on 01/09/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 268.30 on 01/03/24 |
Key Statistics | |||||
Market Capitalization, $K | 18,099,698 | 144,488,960 | 81,266,176 | 77,035,920 | 29,429,788 |
Shares Outstanding, K | 125,946 | 536,376 | 1,245,077 | 711,714 | 145,361 |
Annual Sales | 1,828,290,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,835,600,000 |
Annual Net Income | -440,240,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 1,161,100,000 |
Last Quarter Sales | 439,720,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,386,300,000 |
Last Quarter Net Income | -137,870,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 249,700,000 |
60-Month Beta | 0.39 | 0.58 | 0.19 | 1.41 | -0.02 |
Per-Share Information | |||||
Most Recent Earnings | -1.10 on 02/15/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 3.67 on 04/24/24 |
Latest Earnings Date | 05/02/24 | 05/02/24 | 04/25/24 | 10/31/19 | 04/24/24 |
Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
Ratios | |||||
Price/Earnings ttm | 0.00 | 14.64 | 9.98 | 10.99 | 13.47 |